With advance of an aged society, the populations with lower urinary tract symptoms (LUTS) are increasing. These symptoms can divide into problems with storage (urinary frequent urination, nocturia and urgency) and emptying (incomplete emptying and development of urinary retention). The frequent urination is one of severe urological symptoms caused by the lower urinary tract dysfunction such as overactive bladder (OAB) and benign prostatic hyperplasia (BPH) resulting in bladder outlet obstruction (BOO). Antimuscarinics are the first line treatment at present and show symptom improvement in many patients with frequent urination 1) but are limited by side effects such as dry mouth, blurred vision, constipation and urinary retention in some patients, resulting in a significant level of noncompliance. Therefore, there are substantial unmet medical needs for novel or more effective agents compared with antimuscarinics. Currently, a number of drugs with a variety of mechanisms are in development.ATP-sensitive potassium channel openers (KCO) and nitric oxide (NO) donors have been possible candidates with novel mechanism for the treatment of frequent urination. Opening the potassium channel in bladder smooth muscles evokes membrane hyperpolarization which reduces calcium influx via a voltage-dependent calcium channel and relaxes the detrusor smooth muscle. Expression of ATP-sensitive potassium channel has been detected in bladder from several species including human and rat.2) KCO such as pinacidil and cromakalim have been shown to inhibit isolated bladder contractions in several species, including humans.3-5) Although cromakalim causes an increase in micturition interval in rats, blood pressure was reduced at the same dose.6) On the other hand, the important action of NO on outflow regions appears to be widely accepted.2) Masuda et al. reported that endogenous and exogenous NO depresses reflex bladder activity by suppressing the excitability and/or release of transmitters from bladder afferent nerves in tests using overactivity of the detrusor induced by capsaicin. 7) Thus, we postulated that a drug that possesses nitrate activity in addition to KCO activity, as well as the bladder selective characteristics, would be more useful in the treatment of frequent urination than a pure KCO.Nicorandil (2-nicotinamidoethyl-nitrate ester), which has been used clinically as treatment for angina and acute heart failure, is a KCO that donates NO. Nicorandil is known to improve coronary circulation without changing the systemic blood pressure in humans.8) The pharmacological effects of nicorandil on frequent urination in three different OAB models in rat were reported recently.9) This study was conducted to confirm whether nicorandil could improve the frequent urination symptom without changing the blood pressure using the BOO rat model, compared with those of a pure KCO, cromakalim and a NO donor, isosorbide dinitrate (ISDN).
MATERIALS AND METHODSTests were conducted on female SD rats (140-200 g, Japan SLC, Inc., Shizuoka, Japan). A...